Table 1 Some basic characteristics of patients with liver cancer, hemangioma, non-alcohol fatty liver, and normal liver diagnosis
Characteristic | Liver cancer (n = 153) | Hemangioma (n = 178) | Non-alcohol fatty liver (n = 403) | Normal (n = 449) |
|---|---|---|---|---|
Demographic information | ||||
 Age, year, mean ± standard deviation | 66.6 ± 0.93 | 57.2 ± 0.85 | 51.4 ± 0.68 | 51.8 ± 0.63 |
 Male gender, n (%) | 101 (66.0) | 85 (47.8) | 233 (57.8) | 228 (50.8) |
 Drug allergy history, n (%) | 13 (8.5) | 23 (12.9) | 80 (19.9) | 58 (12.9) |
 Outpatient admission, n (%) | 130 (85.0) | 164 (92.1) | 321 (79.7) | 407 (90.6) |
Comorbidity condition, n (%) | ||||
 Coronary heart disease | 13 (8.5) | 10 (5.6) | 27 (6.7) | 31 (6.9) |
 Diabetes mellitus without complication | 28 (18.3) | 18 (10.1) | 90 (22.3) | 57 (12.7) |
 Diabetes mellitus with complication | 7 (4.6) | 8 (4.5) | 44 (10.9) | 21 (4.7) |
 Essential hypertension | 61 (39.9) | 61 (34.3) | 169 (41.9) | 116 (25.8) |
 Disorders of lipid metabolism | 3 (2.0) | 21 (11.8) | 135 (33.5) | 71 (15.8) |
 Other gastrointestinal disorders | 23 (15.0) | 31 (17.4) | 61 (15.1) | 67 (14.9) |
Laboratory test, n (%) | ||||
 Abnormal urine leukocytes | 13 (8.5) | 17 (9.6) | 37 (9.2) | 34 (7.6) |
 Abnormal urine bilirubin | 4 (2.6) | 2 (1.1) | 8 (2.0) | 9 (2.0) |
 Abnormal urobilinogen | 9 (5.9) | 3 (1.7) | 12 (3.0) | 17 (3.8) |
 Abnormal urine glucose | 9 (5.9) | 14 (7.9) | 56 (13.9) | 42 (9.4) |
 Abnormal urine occult blood | 20 (13.1) | 18 (10.1) | 25 (6.2) | 37 (8.2) |
 Abnormal ketone | 12 (7.8) | 16 (9.0) | 38 (9.4) | 31 (6.9) |